Opinion/decision on a Paediatric investigation plan (PIP): Ocaliva, Obeticholic acid, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0287/2023

Opinion/decision on a Paediatric investigation plan (PIP): Cometriq, cabozantinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0309/2023

Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0338/2023

Human medicines European public assessment report (EPAR): Viekirax, ombitasvir,paritaprevir,ritonavir, Date of authorisation: 14/01/2015, Revision: 28, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Exviera, dasabuvir, Date of authorisation: 14/01/2015, Revision: 26, Status: Withdrawn (authorisation)

PSUSA/00010583/202401

Quality and equivalence of locally applied, locally acting cutaneous products - Scientific guideline

Human medicines European public assessment report (EPAR): Imatinib Teva, imatinib, Date of authorisation: 07/01/2013, Revision: 20, Status: Authorised

Organisation chart: Veterinary Medicines

Organisation chart: Information Management